Severstal Makes Renewed Bid to Acquire Esmark Steel

OAO Severstal, one of the world's leading metals and mining companies, today sent the following letter to the Board of Directors of Esmark Incorporated (NSDQ: ESMK; “Esmark”) with respect to Severstal’s previously announced all cash $17 per share tender offer to acquire all of the outstanding shares of Esmark common stock.

* * * * *

June 19, 2008

Board of Directors

Esmark Incorporated

1134 Market Street

Wheeling, WV 26003

Attention: Mr. James Bouchard

Chairman and Chief Executive Officer

Dear Mr. Bouchard:

We would like to reiterate our continued strong interest in acquiring Esmark Incorporated pursuant to our previously announced tender offer for all outstanding shares of Esmark common stock. We also believe that Severstal is uniquely positioned to promptly consummate an acquisition of Esmark, given the full and enthusiastic support of our proposal by the United Steelworkers and your majority shareholder.

We understand that the arbitrator in the United Steelworkers’ right to bid grievance arbitration with Esmark may consider setting aside Esmark’s Memorandum of Agreement with Essar Steel Holdings Limited.

If the arbitrator sets aside the Memorandum of Agreement, Severstal is aware of and understands Esmark’s financing issues with respect to the loan agreements you entered into with Essar Steel and your other financing agreements. This is to confirm that we are prepared to immediately replace the Essar financing in a manner that satisfies Esmark’s obligations to all credit parties and does not jeopardize Esmark’s business.

We stand ready to conclude a transaction expeditiously.

We look forward to hearing from you.

Sincerely,

By /s/ Gregory Mason
Name: Gregory Mason
Title: Chief Operating Officer OAO SEVERSTAL

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.